Physician profile
William T Joyner
NPI 1730292905
$1,283.65
in general payments reported to CMS, 2019-2025
15 companies · $47.95 in 2025
The $47.95 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $129 · 2020: $325 · 2021: $380 · 2022: $194 · 2023: $70.20 · 2024: $139 · 2025: $47.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $256.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $345.68 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $138.15 | 2021-2025 | |
| Pfizer INC. | $125.09 | 2019-2024 | |
| Evofem Biosciences, INC. | $113.47 | 2020-2022 | |
| Allergan, INC. | $92.02 | 2019-2020 | |
| Therapeuticsmd, INC. | $85.10 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $70.17 | 2023-2024 | Myfembree |
| Lupin INC. | $66.65 | 2019-2021 | |
| Genentech USA, INC. | $65.35 | 2020-2021 | |
| Astellas Pharma US INC | $55.54 | 2023-2024 | Veozah |
| Myovant Sciences INC. | $30.86 | 2021-2022 | |
| Hologic Sales and Service, LLC | $30.20 | 2022 | |
| Virtus Pharmaceuticals LLC | $29.77 | 2021-2022 | |
| Ascend Therapeutics US, LLC | $20.44 | 2020 | |
| Exeltis, USA INC. | $15.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Joyner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.